Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias

American Journal of Surgical Pathology

Volumn 25, Issue 7, 2001, Pages 930-935

  Baak, Jan P A ^a,b,d,e   Ørbo, Anne ^c   Van Diest, Paul J ^a   Jiwa, Mehdi ^b   De Bruin, Peter ^b   Broeckaert, Marc ^a   Snijders, Wim ^b   Boodt, P Jan ^b   Fons, Guus ^b   Burger, Curt ^a   Verheijen, Renee H M ^a   Houben, Paul W H ^b   The, H Sien ^b   Kenemans, Peter ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c UNIVERSITY OF TROMSØ   (Norway)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endometrium; Hyperplasia; Morphometry; Progression; WHO

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; D SCORE; DIAGNOSTIC TEST; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTICENTER STUDY; PREDICTION; PROSPECTIVE STUDY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; WORLD HEALTH ORGANIZATION;

EID: 0034956638     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200107000-00012     Document Type: Article

References (18)

1. Nuclear morphometry in the determination of the prognosis of endometrial hyperplasia
2. The additional prognostic value of morphometric nuclear arrangement and DNA-ploidy to other morphometric and stereologic features in endometrial hyperplasias
3. Architectural and nuclear morphometric features together are more important prognosticators in endometrial hyperplasia than nuclear features alone
4. Assessment of risk of endometrial cancer in hyperplasia, by means of morphologic and morphometric features
5. Multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens
6. Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function
7. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer
8. Announcement: FIGO stages, 1988 revisions
9. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma
10. The behavior of endometrial hyperplasia: A long-term study of 'untreated' hyperplasia in 170 patients
11. Endometrial carcinoma: Clinical and pathologic features
12. Endometrial precancer diagnosis by histopathology, clonal analysis and computerized morphometry
13. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
14. Endometrial intraepithelial neoplasia: (EIN): Will it bring order to chaos?
15. Computerized morphometric analysis in endometrial hyperplasia for the prediction of cancer development: A long term population based retrospective study from northern Norway
16. Eccrine corpus
17. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia